Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:TLMD SOC Telemed (TLMD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About SOC Telemed Stock (NASDAQ:TLMD) 30 days 90 days 365 days Advanced Chart Ad DTIMost folks make this mistake with their investingMost folks could be making a critical mistake with their trading… They’re almost completely ignoring oil. I’ve been trading oil for 20 years, and I’ve discovered something almost nobody else seems to know about. You see, there’s a special type of trade that takes advantage of this narrow range… And it allows us to target what could be meaningful payouts every single week… While also limiting our downside.Go here to get all the details, I call it the “The Oklahoma Trade” Get SOC Telemed alerts:Sign Up Key Stats Today's Range$3.00▼$3.0050-Day Range$2.90▼$3.0052-Week Range$0.55▼$8.00VolumeN/AAverage Volume1.28 million shsMarket Capitalization$302.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSOC Telemed, Inc. provides acute care telemedicine services and technology to hospitals, health systems, physician groups, and government organizations in the United States. The company's Telemed IQ, a cloud-based software platform provides telemedicine solutions. Its telemedicine solutions include teleNeurology, telePulmonology, telePsychiatry, telecardiology, teleCritical Care (ICU), and other specialties. The company was founded in 2004 and is based in Herndon, Virginia. As of April 6, 2022, SOC Telemed, Inc. was taken private.Read More… Most folks make this mistake with their investing (Ad)Most folks could be making a critical mistake with their trading… They’re almost completely ignoring oil. I’ve been trading oil for 20 years, and I’ve discovered something almost nobody else seems to know about. You see, there’s a special type of trade that takes advantage of this narrow range… And it allows us to target what could be meaningful payouts every single week… While also limiting our downside.Go here to get all the details, I call it the “The Oklahoma Trade” Receive TLMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SOC Telemed and its competitors with MarketBeat's FREE daily newsletter. Email Address TLMD Stock News HeadlinesTrial reveals success of telemedicine-supported, village doctor–led approach to managing atrial fibrillationSeptember 3, 2024 | msn.comExplore the Innovations of Dr. Todd H. Lanman: An Influence in Spinal NeurosurgeryAugust 27, 2024 | usatoday.comCRUSHED: How Biden's Replacement Will Devastate Your 401(k)!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.October 13, 2024 | Golden Crest (Ad)Telemedicine usage can have unexpected impact on rural communities' access to local careAugust 3, 2024 | msn.comAccess to remote learning, telemedicine during extreme weather events ending for millionsMay 2, 2024 | nypost.comUT Southwestern, Dallas telemedicine company partner on study to improve heart health in rural communitiesApril 4, 2024 | bizjournals.com(LEAD) Gov't to fully allow telemedicine services in case of doctors' collective actionFebruary 19, 2024 | msn.comCan telemedicine be an alternative to on-site physiotherapy care?February 2, 2024 | msn.comSee More Headlines TLMD Stock Analysis - Frequently Asked Questions How were SOC Telemed's earnings last quarter? SOC Telemed, Inc. (NASDAQ:TLMD) posted its quarterly earnings data on Friday, November, 12th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.09. The firm earned $26.68 million during the quarter, compared to analyst estimates of $25.90 million. SOC Telemed had a negative net margin of 53.52% and a negative trailing twelve-month return on equity of 34.32%. What other stocks do shareholders of SOC Telemed own? Based on aggregate information from My MarketBeat watchlists, some other companies that SOC Telemed investors own include Meta Platforms (META), Advanced Micro Devices (AMD), Asana (ASAN), NVIDIA (NVDA), QUALCOMM (QCOM), Velodyne Lidar (VLDR) and Axcelis Technologies (ACLS). Company Calendar Last Earnings11/12/2021Today10/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Miscellaneous Health & Allied Services Sub-IndustryN/A Current SymbolNASDAQ:TLMD CUSIPN/A CIK1791091 Webwww.soctelemed.com Phone866-483-9690FaxN/AEmployees226Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.57) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-50,540,000.00 Net Margins-53.52% Pretax Margin-53.68% Return on Equity-34.32% Return on Assets-20.96% Debt Debt-to-Equity Ratio0.52 Current Ratio3.32 Quick Ratio3.28 Sales & Book Value Annual Sales$94.44 million Price / Sales3.20 Cash FlowN/A Price / Cash FlowN/A Book Value$1.66 per share Price / Book1.81Miscellaneous Outstanding Shares100,840,000Free Float93,882,000Market Cap$302.52 million OptionableOptionable Beta-1.44 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:TLMD) was last updated on 10/13/2024 by MarketBeat.com Staff From Our PartnersHave you heard of Donald Trump’s Project Crypto?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | Sponsored$20 = Ounce of Gold?I've discovered a way to get exposure to MORE than an ounce of gold... for under $20. It's not bullion. It'...Monument Traders Alliance | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOC Telemed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SOC Telemed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
